Physician profile
Preeti Singh
NPI 1790958817
$579.31
in general payments reported to CMS, 2019-2025
13 companies · $32.73 in 2025
The $32.73 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $63.73 · 2023: $42.56 · 2024: $135 · 2025: $32.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $209.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.03 | 2019-2020 | |
| Novo Nordisk INC | $132.57 | 2019-2023 | Wegovy |
| Stryker Corporation | $116.13 | 2024 | Inbone |
| Aimmune Therapeutics, INC. | $32.73 | 2025 | Zenpep |
| Amgen INC. | $26.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.46 | 2019-2020 | |
| Dexcom, INC. | $18.42 | 2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $17.60 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.76 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.39 | 2020 | |
| Merck Sharp & Dohme LLC | $12.42 | 2019 | |
| Lilly USA, LLC | $10.90 | 2019 | |
| Veran Medical Technologies, INC. | $10.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeti Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.